#Research
Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimera doi.org/10.1186/s435...
#RegulatoryTcells #CD47 #PD_L1 #Immunotherapy #TME #AptamersiRNAchimera
Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimera doi.org/10.1186/s435...
#RegulatoryTcells #CD47 #PD_L1 #Immunotherapy #TME #AptamersiRNAchimera
Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimera - Molecular Biomedicine
Tumor-infiltrating regulatory T (Treg) cells contribute to immune evasion and are associated with poor prognosis in solid tumors. While CD47 blockade has demonstrated efficacy in hematologic malignanc...
doi.org
December 19, 2025 at 5:59 AM
#Research
Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimera doi.org/10.1186/s435...
#RegulatoryTcells #CD47 #PD_L1 #Immunotherapy #TME #AptamersiRNAchimera
Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimera doi.org/10.1186/s435...
#RegulatoryTcells #CD47 #PD_L1 #Immunotherapy #TME #AptamersiRNAchimera